Brief: Bioxcel Therapeutics Granted Extension To Regain Compliance With Nasdaq Continued Listing Requirement
27/05/2025 13:11
May 27 (Reuters) - BioXcel Therapeutics Inc BTAI.O: BIOXCEL THERAPEUTICS GRANTED EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENT Source text: ID:nGNX3SHs8P Further company coverage: BTAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty